Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study - Wikidata - awgldk - TriplyDB

Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study

Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study

http://www.wikidata.org/entity/Q33598258

about

Weight gain after fecal microbiota transplantation Fecal Microbiota Transplantation: Current Applications, Effectiveness, and Future Perspectives Gut microbiota in autism and mood disorders Fecal microbiota transplantation for the treatment of Clostridium difficile infection Microbiology and ecology are vitally important to premedical curricula Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook Fecal Microbiota-based Therapeutics for Recurrent Clostridium difficile Infection, Ulcerative Colitis and Obesity Treating Obesity and Metabolic Syndrome with Fecal Microbiota Transplantation Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection A Review of Experimental and Off-Label Therapies for Clostridium difficile Infection The intestinal microbiome and surgical disease.Dynamic changes in short- and long-term bacterial composition following fecal microbiota transplantation for recurrent Clostridium difficile infection.Faecal microbiota transplant for recurrent Clostridium difficile infection using long-term frozen stool is effective: clinical efficacy and bacterial viability data.Safety and Durability of RBX2660 (Microbiota Suspension) for Recurrent Clostridium difficile Infection: Results of the PUNCH CD Study.Friends with social benefits: host-microbe interactions as a driver of brain evolution and development?Fecal microbiota transplantation for the management of Clostridium difficile infection Microbiome manipulation with faecal microbiome transplantation as a therapeutic strategy in Clostridium difficile infection Clostridium difficile infection: current, forgotten and emerging treatment options.Simple faecal preparation and efficacy of frozen inoculum in faecal microbiota transplantation for recurrent Clostridium difficile infection--an observational cohort study.Diverticulitis after fecal microbiota transplant for C. difficile infection.The microbiome of the urinary tract--a role beyond infection.Effectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent Clostridium difficile infection.Fecal microbiota transplantation as novel therapy in gastroenterology: A systematic review Multiscale analysis of the murine intestine for modeling human diseases.Fecal microbiota transplantation for Clostridium difficile infection: back to the future.Feces transplantation for recurrent Clostridium difficile infection: US experience and recommendations.Recurrent Clostridium difficile infection and the microbiome.[The microbiome of the gut in critically ill patients].Understanding Luminal Microorganisms and Their Potential Effectiveness in Treating Intestinal Inflammation Donor Species Richness Determines Faecal Microbiota Transplantation Success in Inflammatory Bowel Disease Clostridium difficile drug pipeline: challenges in discovery and development of new agents Systematic review with meta-analysis: long-term outcomes of faecal microbiota transplantation for Clostridium difficile infection.Changes in Colonic Bile Acid Composition following Fecal Microbiota Transplantation Are Sufficient to Control Clostridium difficile Germination and Growth.Breakthroughs in the treatment and prevention of Clostridium difficile infection.On the Origins and Control of Community Types in the Human Microbiome Economic evaluation of fecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection in Australia.Structural and functional changes within the gut microbiota and susceptibility to Clostridium difficile infection.Minimum Requirements for Reporting Fecal Microbiota Transplant Trial Host-microbe interaction: Rules of the game for microbiota.Universality of human microbial dynamics

P2860

Q22305013-1E8A5C0A-D8CB-490D-9863-B628A76CEB06 Q26767161-BF23F00C-F374-49E1-A511-16BD87B12A25 Q26772308-B1609F80-7A10-4E60-8854-90CF6ED5E910 Q26783516-E8E7DF97-8FFC-451A-9931-821D26B6F693 Q26801329-A2947786-B18C-4623-8740-AB44FEEE59B8 Q26995945-465AAE83-E7A2-473C-A0B9-4710C6D466B7 Q28070349-72BAE238-0E31-4101-82C1-33E0FF9681CB Q28078234-5337BDF8-BDED-46D2-8F8A-981B901565BF Q28258066-2BDC3FE1-DF65-4F27-92FB-673FC6D95B6B Q30240264-1F4D4CFF-D077-46A3-9008-1971E0457936 Q30248605-F5D27CE5-5BBD-4312-813E-880D0B308973 Q30633072-1B0A8E24-938B-4522-97DC-6ACD987C0EA9 Q30986751-D0B7F413-4208-4266-81B7-99811F694FDE Q33466550-E5D504E1-7C51-444A-B0B7-DE8DC2A76D4B Q34419563-7A857BBF-8506-4250-AAF8-2E939F32EAEB Q35083682-531927FE-C69B-4E5F-B175-113659350410 Q35240464-BB1B2BEB-BA5D-43F2-A8BF-E997CE6EC880 Q35372397-8CCD52A7-6EEB-45D9-A30D-8CE7E864B456 Q35376007-F582A01C-63CA-4709-898C-4255BE37B4D4 Q35485128-2BF26AB0-7F46-404B-BE1C-E376AD22F240 Q35544680-41E0B4E4-C18E-411D-9D20-3BD3768A67CB Q35605686-0F46456F-10A6-4E44-9A6B-768F6F6E6BDA Q35624960-F18459DA-43BD-4CD7-AF1F-4C750AA07EBB Q35651919-8319A3F3-D779-45A7-8F19-2DCDB063B47F Q35660581-5B1BC06F-B520-44F9-87B7-516EAC3864E6 Q35671153-0ABCC31C-7D53-4458-8240-C20EDF4BE028 Q35685694-AC9AAA09-B377-463F-954A-CA27F46316D9 Q35766204-DA2FA9CC-F986-4D57-B32A-8B937D18790A Q35803240-03431616-F09F-43BD-8F5F-B52BACE292DB Q35828147-5A77057E-3FB0-40F6-A82F-71C4F56F2204 Q35846436-DA5E41F8-5BD5-44F8-BD83-395C0FC96FDB Q35867850-964D1D4E-7653-416A-BC81-BF7E6BE67271 Q35899010-E2B3902B-3574-4CD2-AD11-6265D35E0813 Q35918566-7B01177F-EEC4-4E8A-A470-498D654F1F0E Q35920767-98B0F5B7-D798-4185-9FA1-7BBDBAC25031 Q35979116-6B1D8E16-D72B-4B63-A55B-56250993EC8A Q36018079-BD2AA3B6-5DC2-4C7D-8A71-567F1E2A841B Q36029578-BF3E3086-0E1E-43EB-9FB3-968D56BD85C8 Q36045863-4D1FF990-0589-4CE8-84B8-66F64646B9F6 Q36045881-1A205541-FE86-4117-8361-0855F5201A4A

P2860

Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study

http://www.wikidata.org/entity/Q33598258

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Fecal microbiota transplant fo ...... -label, controlled pilot study

@ast

Fecal microbiota transplant fo ...... -label, controlled pilot study

@en

type

label

Fecal microbiota transplant fo ...... -label, controlled pilot study

@ast

Fecal microbiota transplant fo ...... -label, controlled pilot study

@en

prefLabel

Fecal microbiota transplant fo ...... -label, controlled pilot study

@ast

Fecal microbiota transplant fo ...... -label, controlled pilot study

@en

P1433

Q33598258-4978155C-7215-451B-8B58-AF24B19F1015

P1476

Q33598258-64B915B4-49A0-4847-84B8-B6B43CE75CFC

P2093

Q33598258-7BF0BAE5-ABA1-4C19-BF81-3BD4C1458337

Q33598258-973231BB-5B49-46E2-9783-868F1839BE9B

Q33598258-9C8F11DA-6111-40DC-BC08-038239A61A29

Q33598258-C03447F6-2FA6-42AB-A878-75EF2419B972

Q33598258-CB8AD3A3-EEEE-47FA-9A12-8F3B4D677F0F

Q33598258-DA1E93E4-D79C-40D4-849C-FB19DB2448AF

Q33598258-ED0E0E5F-628C-4936-8EC0-01883DC7F56D

Q33598258-ED90E77E-1E26-4268-AC46-4C8B2331A4E1

P2860

Q33598258-18F77CB6-2CA5-47C6-AD6E-D8895CFFE4AB

Q33598258-1C977C6A-BE13-454A-8007-380B445B37C8

Q33598258-3D856611-A44A-443F-A60C-3DAA35F57903

Q33598258-3FA93DF7-BB8A-4AA3-BEA4-E116AF6DA4C1

Q33598258-4BBAA861-DD6E-400F-B260-A8C87398B28A

Q33598258-4E136994-BD20-4315-9D6B-0D63F9710D59

Q33598258-4E3A71CD-98B3-4B04-AF67-24E1B8986A18

Q33598258-566B9444-5FA3-423C-B7F1-F9025FE51856

Q33598258-5F1E3EC1-485F-4C82-927F-7AC78D4820A9

Q33598258-63C2CE4A-CAB4-49F8-B6AF-975DD50A89FA

P304

Q33598258-6D23C984-FD5D-41F5-AE06-3E55CEE45E1C

P31

Q33598258-C1E889DD-0902-4356-AB99-B62B2695D20B

P356

Q33598258-186A9A0D-2C60-45A1-802A-994F230B7493

P407

Q33598258-B8082520-9B09-45BF-B700-6FE03659E3EB

P433

Q33598258-BE16613C-0087-4876-9EC9-ACC2C294DCD6

P478

Q33598258-800957E8-8C85-42D7-97E8-0A0414F21580

P50

Q33598258-4D70868F-444A-4323-819A-9AB22FBC725F

Q33598258-5D40E6AC-902F-4C7F-B6F9-146980A73605

P577

Q33598258-9AB39BAB-C772-489E-89ED-79205F109247

P5875

Q33598258-ECBDC682-8701-4725-88C5-3264D53E157D

P698

Q33598258-54808CEE-1498-432B-80A8-8C02C05350DE

P921

Q33598258-CAAAEA00-321B-4019-9917-E8935C56586F

Q33598258-E9A944D8-DF78-4158-8265-340BD3DA99A1

P932

Q33598258-0C1637BC-2B38-4906-B0DD-B1DA31E24C61

P356

P1433

Clinical Infectious Diseases

P1476

Fecal microbiota transplant fo ...... -label, controlled pilot study

@en

P2093

Christina Pindar

http://www.w3.org/2001/XMLSchema#string

Elizabeth L Hohmann

http://www.w3.org/2001/XMLSchema#string

Eric J Alm

http://www.w3.org/2001/XMLSchema#string

George H Russell

http://www.w3.org/2001/XMLSchema#string

Jenny Sauk

http://www.w3.org/2001/XMLSchema#string

Jess L Kaplan

http://www.w3.org/2001/XMLSchema#string

Mark B Smith

http://www.w3.org/2001/XMLSchema#string

Robin G Wilson

http://www.w3.org/2001/XMLSchema#string

P2860

Treating Clostridium difficile infection with fecal microbiota transplantation

Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease

Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results

Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection

Duodenal infusion of donor feces for recurrent Clostridium difficile

Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms

Clostridium difficile infection: new developments in epidemiology and pathogenesis

Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube.

Fidaxomicin versus vancomycin for Clostridium difficile infection.

Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice

P304

1515-1522

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CID/CIU135

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-04-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261881418

http://www.w3.org/2001/XMLSchema#string

P698

24762631

http://www.w3.org/2001/XMLSchema#string

P921

Clostridium difficile

P932

4017893

http://www.w3.org/2001/XMLSchema#string